| Members |
targetComponentId |
| Salmonella nienstedten |
Salmonella Ohio var 14+ |
| Salmonella nuernberg |
Salmonella II 42:z:z6 |
| Salmonella odjik |
Salmonella II 30:a:z39 |
| Salmonella omderman |
Salmonella Amersfoort var 14+ |
| Salmonella oysterbeds |
Salmonella II 6,7:z:z42 |
| Salmonella pankow |
Salmonella Shangani var 15+ (organism) |
| Salmonella IV parera (living organism) |
Salmonella IV 11:z4,z23:- |
| Salmonella portbech |
Salmonella II 42:l,v:e,n,x,z15 |
| Salmonella portsmouth (organism) |
Salmonella London var 15+ |
| Salmonella pullorum (organism) |
Salmonella Pullorum |
| Salmonella rosenthal |
Salmonella enterica subspecies enterica serovar Butantan var O:15, 34+ (organism) |
| Salmonella rutgers |
Salmonella 3,10:R1,z40:1,7 (organism) |
| Salmonella saka |
Salmonella Sya (organism) |
| Salmonella salinatis |
Salmonella Duisburg (organism) |
| Salmonella selandia |
Salmonella Nyborg var 15+ |
| Salmonella serotype B,:r:- |
Salmonella serotype B,:r:- (organism) |
| Salmonella thielallee (organism) |
Salmonella Oranienburg var 14+ |
| Salmonella thomasville (organism) |
Salmonella Orion var 15+, 34+ |
| Salmonella tournai |
Salmonella Stockholm var 15+ |
| Salmonella tuebingen |
Salmonella Amager var 15+ |
| Salmonella veddel |
Salmonella II 43:g,t:[1,5] |
| Salmonella wildwood |
Salmonella Meleagridis var 15+, 34+ |
| Salmonella zuerich |
Salmonella II 1,9,12,46,27:c:z39 |
| Salmonella, Subgenus I (organism) |
Salmonella enterica subsp. enterica (organism) |
| Salmonella, Subgenus II |
Salmonella enterica subsp. salamae (organism) |
| Salmonella, Subgenus III |
Salmonella enterica subsp. arizonae (organism) |
| Salmonella, Subgenus IV |
Salmonella enterica subsp. houtenae (organism) |
| Salmonella, Subgenus V (organism) |
Salmonella bongori (organism) |
| aliment : sandwich |
Sandwich (substance) |
| Saphenous vein graft replacement of four or more coronary arteries |
Aortocoronary artery bypass of four or more coronary arteries with saphenous vein graft (procedure) |
| Saphenous vein graft replacement of one coronary artery |
Aortocoronary artery bypass of one coronary artery with saphenous vein graft (procedure) |
| Saphenous vein graft replacement of three coronary arteries |
Aortocoronary artery bypass of three coronary arteries with saphenous vein graft (procedure) |
| Saphenous vein graft replacement of two coronary arteries |
Aortocoronary artery bypass of two coronary arteries with saphenous vein graft (procedure) |
| Saquinavir 200mg capsule (product) |
Saquinavir (as saquinavir mesylate) 200 mg oral capsule |
| Saquinavir 500mg tablet (product) |
Saquinavir (as saquinavir mesylate) 500 mg oral tablet |
| Saquinavir mesylate 200mg capsule (product) |
Saquinavir (as saquinavir mesylate) 200 mg oral capsule |
| Saquinavir mesylate 200mg capsule |
Saquinavir (as saquinavir mesylate) 200 mg oral capsule |
| Sarcoidosis, anular type (disorder) |
Annular sarcoidosis (disorder) |
| Sarcoma - category (morphologic abnormality) |
Sarcoma (morphologic abnormality) |
| Sargramostim 250mcg injection (product) |
Product containing precisely sargramostim 250 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
| Satyriasis |
activité sexuelle excessive (trouble) |
| Savinase specific extract (product) |
Product containing savinase (medicinal product) |
| Scaling |
Desquamation, function (observable entity) |
| Scallop - dietary |
Scallop (substance) |
| Scalp flap |
Flap (substance) |
| Scalp random pattern flap |
Random pattern flap |
| Scalpel wound as birth trauma |
Accidental laceration during a procedure (disorder) |
| plaie par scalpel due à un traumatisme à la naissance |
Accidental laceration during a procedure (disorder) |
| Scanning (procedure) |
Action |
| Scanning-tunnelling (procedure) |
Action |
| Scapular axial pattern flap |
Axial pattern flap |
| Scapular fasciocutaneous flap |
Fasciocutaneous flap |
| Scapular fasciocutaneous flap plus scapula |
Osteofasciocutaneous flap (substance) |
| Scapulohumeral fibrositis |
Scapulohumeral fibrositis |
| Scar of posterior pole of retina (disorder) |
Scar of posterior pole of retina (disorder) |
| Scarring |
Scar |
| Schistosome |
Schistosoma (organisme) |
| Schmidt's syndrome |
Polyglandular autoimmune syndrome, type 2 |
| Schmorl's nodes of other region, NEC |
nodules de Schmorl |
| Schonell graded word reading test |
Schonell graded reading test (assessment scale) |
| Schonell graded word spelling test |
Schonell graded spelling test (assessment scale) |
| School maladjustment |
School maladjustment |
| Scleroderma syndrome |
sclérodermie systémique |
| Scoliosis (disorder) |
scoliose posturale congénitale |
| Scopolamine 0.5mg/24 hr patch (product) |
Product containing only scopolamine in transdermal dose form (medicinal product form) |
| Scopolamine hydrobromide 0.25% solution (product) |
Product containing precisely scopolamine (as scopolamine hydrobromide) 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) |
| Scopulariopsis koningii |
Scopulariopsis brevicaulis (organisme) |
| Screwing - action |
action : insertion |
| Screws up eyes |
Inappropriate movement of face |
| Screws up face |
Inappropriate movement of face |
| Scrofula (disorder) |
Scrofuloderma |
| Scrotal flap |
Flap (substance) |
| Sebaceous epithelioma |
Sebaceous adenoma |
| Second diphtheria and tetanus double vaccination |
Administration of second dose of diphtheria and tetanus vaccine |
| Second diphtheria and tetanus double vaccination |
Administration of second dose of diphtheria and tetanus vaccine |
| Second diphtheria, pertussis and tetanus triple vaccination |
Administration of second dose of diphtheria, pertussis, and tetanus vaccine |
| Second glass clear |
Second glass clear |
| Second glass contains mucous |
Second glass contains mucous (finding) |
| Second glass contains specks or sediments |
Second glass contains specks or sediments |
| Second glass contains threads or strands |
Second glass contains threads or strands |
| Second toe flap |
Flap (substance) |
| Secondary and unspec malig neop pulmonary lymph nodes (disorder) |
Metastatic malignant neoplasm to lymph node |
| Secondary hemorrhage due to and following illegally induced termination of pregnancy |
Secondary haemorrhage due to and following induced termination of pregnancy |
| Secondary hemorrhage due to and following legally induced termination of pregnancy |
Secondary haemorrhage due to and following induced termination of pregnancy |
| Secondary hyperoxaluria (disorder) |
Secondary oxalosis |
| Secondary hypogonadism (disorder) |
hypogonadisme hypogonadotrope (trouble) |
| Secondary idiopathic telangiectasia |
Secondary telangiectasia (disorder) |
| Secondary localized osteoarthrosis of thigh |
Disorder of lower extremity (disorder) |
| Secondary malignant neoplasm of small intestine and duodenum |
Metastatic malignant neoplasm to small intestine |
| Secondary malignant neoplastic process |
Neoplasm, metastatic |
| Secondary nephrogenic diabetes insipidus |
Nephrogenic diabetes insipidus |
| Secondary osteosarcoma |
Secondary osteosarcoma following treatment or precursor disease (morphologic abnormality) |
| Secondary syphilis of other viscera |
syphilis secondaire des viscères |
| Secondary transvestism |
Secondary transvestism (finding) |
| Secretin 40mcg powder for injection solution vial (product) |
Product containing only secretin in parenteral dose form (medicinal product form) |
| Secretory otitis media (disorder) |
Chronic mucoid otitis media |
| Sedating antihistamine (substance) |
antihistaminique |
| Sedating antihistamine adverse reaction |
Adverse reaction caused by antihistamines (disorder) |
| Sedative dependence (finding) |
Sedative dependence (disorder) |
| Sedative dependence with current use (disorder) |
Sedative dependence (disorder) |
| Seizure disorder clinical management plan (qualifier value) |
Seizure disorder clinical management plan |
FHIR